June 2021 Issue

GO TO FULL ISSUE

Get evidence-based advice on drug information and current guidelines, plus the CE you need. Subscribe. Pharmacist's Letter Canada

MED UPDATES

Corzyna
ranolazine
An antianginal add-on therapy for patients with stable angina who are inadequately controlled or intolerant to first-line therapies

Kesimpta
ofatumumab
A monoclonal antibody for relapsing-remitting multiple sclerosis

Zeposia
ozanimod
An oral sphingosine 1-phosphate receptor modulator for relapsing-remitting MS

MORE MED UPDATES